Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
BioTime, Inc.
(NY:
BTX
)
4.190
USD
+0.270 (+6.89%)
Official Closing Price
/ Updated:
4:15 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about BioTime, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
LifeMap Sciences, a Subsidiary of BioTime, Reports Its Databases Currently Utilized by an Estimated Two Million Unique Visitors Annually according to Google Analytics
February 11, 2013
from
Business Wire News Releases
AMEX Stocks Mostly Higher (OBT, BTX, CRC, PDO, TGC)
February 04, 2013
Las Vegas, NV -- (SBWIRE) -- 02/04/2013 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume leaders as reported by Beststocksdaily.
Read More
from
SBWire - Latest Press Releases
BioTime (BTX) Unit Updates on Plans for PanC-Dx Development
January 31, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8046818 for the full story.
Read More
from
StreetInsider.com News Articles
BioTime’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTM
January 31, 2013
from
Business Wire News Releases
LifeMap Sciences, a Subsidiary of BioTime, Announces Publication of Research Report Describing Non-Redundant Compendium of Human Non-Coding RNA Authored by GeneCards® Scientists
January 30, 2013
from
Business Wire News Releases
Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013
January 28, 2013
Five Star Equities Provides Stock Research on Astex Pharmaceuticals and BioTime
Read More
from
Marketwired News Releases
AMEX Stocks Trading Lower (VRNG, GPL, ONP, REE, BTX)
January 24, 2013
Las Vegas, NV -- (SBWIRE) -- 01/24/2013 -- PennyStockParlay.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
BioTime CEO Dr. Michael West to Present at Scale-Up and Manufacturing of Cell-Based Therapies II Conference
January 18, 2013
from
Business Wire News Releases
AMEX Stocks in Focus (NBS, BTX, DNN, TLR, HUSA)
January 16, 2013
Las Vegas, NV -- (SBWIRE) -- 01/16/2013 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume leaders as reported by Beststocksdaily.
Read More
from
SBWire - Latest Press Releases
AMEX Stocks Alert: CUR, RTK, INO, BTX, NGD
January 14, 2013
Pompano Beach, FL -- (SBWIRE) -- 01/14/2013 -- Csrnewsdaily.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues...
Read More
from
SBWire - Latest Press Releases
BioTime Submits Protocol for Initiation of Human Clinical Trials of Renevia™ in Europe
January 10, 2013
from
Business Wire News Releases
AMEX Stocks Mostly Higher: PAL, DNN, NBS, BTX, ZBB
January 09, 2013
Las Vegas, NV -- (SBWIRE) -- 01/09/2013 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume leaders as reported by Beststocksdaily.
Read More
from
SBWire - Latest Press Releases
LifeMap Sciences, a Subsidiary of BioTime, Inc., Announces the Release of MalaCards Version 1.02
January 09, 2013
from
Business Wire News Releases
4 Biotechnology Stocks to Sell Now
January 09, 2013
Read More
category
Stocks to Sell
,
NASDAQ:IMGN
,
NASDAQ:PGNX
, and 2 more.
from
InvestorPlace - Latest Headlines
Top Narrow Based Indexes For January 8, 2013
January 08, 2013
By 11:20 am, the Dow Jones Industrial Average was down 54.02 points, or 0.40%, to 13,330.27, while the broader Standard & Poor's 500 index had dropped 7.73 points, or 0.53%. The NASDAQ composite index...
Read More
category
Benzinga
,
Movers
,
FREE
, and 9 more.
from
Latest Articles from Benzinga.com
BioTime (BTX) Opens Higher After Announcing Agreement With Geron (GERN)
January 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7990114 for the full story.
Read More
from
StreetInsider.com News Articles
BioTime to Buy Human Embryonic Stem Cell Program Assets of Geron
January 07, 2013
BioTime, Inc. (NYSE: BTX ) and its recently formed subsidiary BioTime Acquisition Corporation (BAC) jointly announced today that they have entered into a definitive Asset Contribution Agreement with...
Read More
category
Benzinga
,
US3741631036
,
Asset Sales
, and 5 more.
from
Latest Articles from Benzinga.com
BioTime Signs Definitive Agreement With Geron Regarding Stem Cell Assets
January 07, 2013
from
Business Wire News Releases
4 Biotechnology Stocks to Sell Now
December 27, 2012
Read More
category
Stocks to Sell
,
NASDAQ:IMGN
,
NASDAQ:PGNX
, and 2 more.
from
InvestorPlace - Latest Headlines
BioTime Announces the Appointment of Jeffrey Janus as Vice President
December 20, 2012
from
Business Wire News Releases
Trader May Repeat the Process of Buying (OREX, BTX, VZ, VOD)
December 19, 2012
Los Angelas, CA -- (SBWIRE) -- 12/19/2012 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks....
Read More
from
SBWire - Latest Press Releases
BioTime Reports Isolation of Seven Diverse Cartilage and Bone Cell Types From Human Embryonic Stem Cells
December 18, 2012
from
Business Wire News Releases
BioTime CEO Dr. Michael West Presents Product Development Update at World Stem Cell Summit 2012
December 04, 2012
from
Business Wire News Releases
BioTime CEO Dr. Michael West to Present at World Stem Cell Summit 2012
November 29, 2012
from
Business Wire News Releases
LifeMap Sciences, a Subsidiary of BioTime, Inc., Launches LifeMap Discovery™: A Database of Human Cellular Life for the Field of Regenerative Medicine
November 27, 2012
from
Business Wire News Releases
BioTime Announces Passing of Director Abraham E. Cohen
November 26, 2012
from
Business Wire News Releases
Biotonix (2010) Inc. : Résultats du troisième trimestre de 2012
November 22, 2012
from
Marketwired
LifeMap Sciences, a Subsidiary of BioTime, Signs Definitive Distribution Agreement with ProSpec-Tany TechnoGene
November 20, 2012
from
Business Wire News Releases
Benzinga's Small Cap Movers for Monday November 19, 2012
November 19, 2012
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: Grupo Casa Saba Shares of Grupo Casa Saba (NYSE: SAB ), the Mexican distributors of pharmaceutical...
Read More
category
Benzinga
,
Movers
,
Global
, and 13 more.
from
Latest Articles from Benzinga.com
LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.09
November 19, 2012
from
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here